NCT04384029View on ClinicalTrials.gov

The Geneva Covid-19 CVD Study

CompletedOBSERVATIONAL
Enrollment

1,927

Participants

Timeline

Start Date

March 24, 2020

Primary Completion Date

June 30, 2021

Study Completion Date

July 31, 2021

Conditions
COVIDCVD
Interventions
OTHER

Covid-19 + patients

all the patients hospitalized in Geneva and SARS-Cov2 positive

Trial Locations (1)

1211

Geneva University Hospital (HUG), Geneva

All Listed Sponsors
lead

François MACH

OTHER

NCT04384029 - The Geneva Covid-19 CVD Study | Biotech Hunter | Biotech Hunter